NBOMes: Difference between revisions

From TripSit wiki
Jump to navigation Jump to search
No edit summary
(Reference fixes, added illegality in USA)
Line 124: Line 124:
== Europe ==
== Europe ==


The NBOMe series of psychoactives became [http://www.rg.ru/2011/10/19/narko-dok.html controlled in the Russian Federation] starting October, 2011.
The NBOMe series of psychoactives became controlled in the Russian Federation] starting October, 2011.<ref>http://www.rg.ru/2011/10/19/narko-dok.html</ref>


The [http://www.legislation.gov.uk/ukdsi/2014/9780111110904 UK Home Office announced that 25I-NBOMe would be made a class A drug] on 10th June 2014 alongside every other N-benzyl phenethylamines.
The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamines.<ref>http://www.legislation.gov.uk/ukdsi/2014/9780111110904</ref>


== America ==  
== America ==  


The NBOMe series of compounds are unscheduled in the United States. It is possible that some of them would be considered analogs (of scheduled phenethylamines such as 2C-B or mescaline), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. However, Virginia has recently made the 25x-NBOMe series and all its analogues schedule I; expected is that more states are to follow quickly.
25i-NBOMe, 25b-NBOMe, and 25c-NBOMe were emergency scheduled by the DEA on Novemeber 15, 2013<ref>http://www.justice.gov/dea/divisions/hq/2013/hq111513.shtml</ref>


= Links =
= Links =
Line 139: Line 139:


[http://www.reddit.com/r/Drugs/comments/14wua3/rdrugs_faq_series_nbome_series_aka_25xnbome/?sort=top /r/Drugs FAQ]
[http://www.reddit.com/r/Drugs/comments/14wua3/rdrugs_faq_series_nbome_series_aka_25xnbome/?sort=top /r/Drugs FAQ]
= References =
<references />


[[Category:Psychedelic]]
[[Category:Psychedelic]]
[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 02:23, 21 July 2014

These chemicals have nearly no history of human use prior to 2010 when they first became available online, and very little is known about this group of compounds. They should only be used with extreme caution. It's recommended to not take more than 1.5 mg of any substance of the NBOMe family, as there have been multiple deaths from people just taking 2-3 blotters.

25I-NBOMe Dosage

Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). NBOMe chemicals are not active orally, and will not work if swallowed. It is recommended to avoid sublingual administration because of the reported bad taste. Buccal administration is common, placing the tab between the upper or lower gum and lip.

Sublingual
Light 200-500 μg
Common 500-1500 μg
Strong 1500+ μg
Insufflated
Light 100-400 μg
Common 400-700 μg
Strong 700+ μg+

25C-NBOMe Dosage

Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).

Sublingual
Light 100-300 μg
Common 300-800 μg
Strong 800+ μg
Insufflated
Light 100-300 μg
Common 300-500 μg
Strong 500+ μg

Duration

Sublingual
Onset 15-45 minutes
Total 4-11 hours
Insufflated
Onset 0-10 minutes
Total 3-8 hours

Effects

Positive

  • Strong open and closed eye visuals, including trails, color shifts, brightening, etc.
  • Mood lift
  • Euphoria
  • Mental and physical stimulation
  • Increase in associative & creative thinking
  • Increased awareness & appreciation of music
  • Life-changing spiritual experiences
  • Erotic, sexual thoughts and sensations
  • Feelings of love and empathy

Neutral

  • General change in consciousness
  • Pupil dilation
  • Difficulty focusing
  • Unusual body sensations (facial flushing, chills, goosebumps, body energy)
  • Change in perception of time, time dilation
  • Slight increase in heart rate
  • Yawning, especially when coming up

Negative

Likelihood of negative side effects increases with higher doses.

  • Confusion
  • Looping
  • Scrambled communication
  • Nausea
  • Insomnia
  • Looping, recursive, out of control thinking
  • Paranoia, fear, and panic
  • Unwanted and overwhelming feelings
  • Unwanted life-changing spiritual experiences

After effects

  • Afterglow
    • An afterglow may be present until a day after use, sometimes more depending on the individual.
  • Long term effects
    • A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMe chemicals.

Harm Reduction

NBOMes are considered less safe than many psychedelics, as they generally have a much lower threshold for overdose and have a much heavier physical effect on the body. Even so, most reports of death by an NBOMe chemical involve mislabeling of the drug (for example: someone insufflates 20mg of 25i-NBOMe because he/she thought it was 2C-I). This chemical is extremely potent and has a relatively low LD50 (LD50 is the dosage at which 50% of the tested population does not survive). Therefore, a mislabeling or misweighing can result in death.

Furthermore, due to the physical strain the drug causes one should not use it if there are any pre-existing heart conditions.

See Psychedelic Harm Reduction for general information.

Legal status

Europe

The NBOMe series of psychoactives became controlled in the Russian Federation] starting October, 2011.[1]

The UK Home Office announced that 25I-NBOMe would be made a class A drug on 10th June 2014 alongside every other N-benzyl phenethylamines.[2]

America

25i-NBOMe, 25b-NBOMe, and 25c-NBOMe were emergency scheduled by the DEA on Novemeber 15, 2013[3]

Links

Wikipedia

Erowid

/r/Drugs FAQ

References